For decades, millions of Americans have taken Zantac (ranitidine) to help with heartburn, indigestion, and other gastrointestinal complaints, both as an over-the-counter drug and in prescription form. However, evidence has recently surfaced that ranitidine can develop dangerous levels of N-nitrosodimethylamine (NDMA) after exposure to heat, prompting the FDA to request that all manufacturers withdraw raniditine medications from the market.
NDMA is defined as a probable carcinogen – and it poses a serious threat to human health when taken in large amounts over a period of time. If you believe that you or a loved one have been diagnosed with cancer due to taking contaminated Zantac, our Memphis Zantac injury lawyers at Gatti, Keltner, Bienvenu & Montesi, PLC, can help you with the process of filing a defective drug lawsuit against the responsible manufacturer.
Contact us today at 901-526-2126 to get started with a free consultation.
While there are trace amounts of NDMA in some of the foods we eat and products we use, this compound has been shown to cause serious side effects and even cancer with long-term exposure. The human body can only process approximately 0.096 micrograms of NDMA each day, which means that food and drug companies have a responsibility to screen for excess NDMA contamination and ensure that their products are safe for mass consumption.
High levels of NDMA have been known to cause the following:
In the case of Zantac, however, the problem is much more severe than just NDMA contamination: In June 2019, online pharmacy and independent lab Valisure discovered that the ranitidine molecule is inherently unstable. This finding prompted the company to file an official Citizen’s Petition with the FDA and ask that all ranitidine products be recalled from shelves and pharmacy counters. In January 2020, another testing lab known as Emery Pharma found that even after Zantac has been packaged, it can develop increased NDMA levels with exposure to high heat.
In April 2020, the FDA told all pharmaceutical companies and drug manufacturers to pull ranitidine medications from the market due to the risk of cancer. Unfortunately, Zantac has long been one of the most popular drugs in America – and while most ranitidine drug manufacturers may have stopped selling their products at this point, the damage has already been done.
Whether you file an individual defective drug lawsuit or join mass tort litigation against a major pharmaceutical manufacturer like Sanofi (the maker of name-brand Zantac), it may be possible to seek compensation for your losses. At Gatti, Keltner, Bienvenu & Montesi, PLC, we’ve been helping injured people since 1970 across Tennessee, Arkansas, and Mississippi. With a strong track record of success and 150 years of combined experience across our practice, we can provide the seasoned and compassionate counsel you deserve in the wake of your injuries.
Give us a call today at 901-526-2126 or submit our online contact form to start exploring your legal options. We are available 24/7 to answer your call.
We are not afraid to go to trial and will fight for every dollar you deserve.
We utilize expert investigators, medical specialists & accident reconstructionists.
We will do whatever it takes to get you the money that you deserve, as quickly as possible.
We have an over 40-year track record of successful verdicts & settlements.
We'll guide you through each step of the process, from the moment you make the first call to the moment you get paid.